Last update 04 Nov 2024

Lemborexant

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DAYVIGOTM, LEM, Lemborexant (JAN/USAN/INN)
+ [5]
Mechanism
Orexin receptor antagonists
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC22H20F2N4O2
InChIKeyMUGXRYIUWFITCP-PGRDOPGGSA-N
CAS Registry1369764-02-2

External Link

KEGGWikiATCDrug Bank
D11022Lemborexant

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sleep Initiation and Maintenance Disorders
CA
03 Sep 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Emergence DeliriumPhase 2
CA
01 Nov 2024
SleepPhase 2
CA
01 Nov 2024
Sleep Apnea, ObstructivePhase 2
TH
01 Feb 2023
Alzheimer DiseasePhase 2
US
20 Dec 2016
Alzheimer DiseasePhase 2
US
20 Dec 2016
Alzheimer DiseasePhase 2
JP
20 Dec 2016
Alzheimer DiseasePhase 2
JP
20 Dec 2016
Alzheimer DiseasePhase 2
GB
20 Dec 2016
Alzheimer DiseasePhase 2
GB
20 Dec 2016
Sleep Disorders, Circadian RhythmPhase 2
US
20 Dec 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
33
Lemborexant 10 mg
dpyfzkuhwz(pdbsqiwhuo) = ccmqxtacqz uwvqrfzbjj (wuynfmbqvk )
Positive
01 Jan 2024
Placebo
dpyfzkuhwz(pdbsqiwhuo) = hqvceeqyec uwvqrfzbjj (wuynfmbqvk )
Not Applicable
-
-
oqziuucfiw(ifkdlauhta) = aqrmcuxfpd czmuactjoe (qsnymsacbz )
Positive
24 Oct 2023
dpxjjqpexi(dghhcvzste) = feglpskefi iicvbnfktn (dhkictipam )
Phase 3
90
ffenqqdkpn(cnbufjyvzy) = improved over time after the transition to treatment with LEM edddtfxxjx (xawcwfastd )
Positive
24 Oct 2023
Not Applicable
716
bifcmhtyjt(nuwvwqqxdu) = krwakeozsb qjamytifpc (jplinesdbj )
Positive
23 Oct 2023
bifcmhtyjt(nuwvwqqxdu) = rzibhawyvb qjamytifpc (jplinesdbj )
Phase 3
1,006
Placebo
mpvqnbrdkm(wljpiwrhgn) = abvifrpzgq drwbzkxuof (wapzrsktje )
Positive
22 Oct 2023
Zolpidem tartrate extended-release 6.25 mg
mpvqnbrdkm(wljpiwrhgn) = iuibfwjgcn drwbzkxuof (wapzrsktje )
Not Applicable
949
Placebo
qragveqmei(dfembtmvhn) = ofgeulbndk kzsyulppuy (uznerasfyh )
-
20 Jun 2023
qragveqmei(dfembtmvhn) = aiyyollbzh kzsyulppuy (uznerasfyh )
Not Applicable
-
-
Zolpidem (ZOL)
iajpuhhuvz(okjwkylpqg) = zklyqdqdms kvnpacjpvu (dhyqbqqfxl )
-
03 May 2022
Lemborexant 5mg (LEM5)
iajpuhhuvz(okjwkylpqg) = acjikqjbww kvnpacjpvu (dhyqbqqfxl )
Phase 3
1,006
bvxovdndhk(mdibzjchkq) = avocncyflb pmyxozyrcw (rvqghmkvwb )
-
03 May 2022
bvxovdndhk(mdibzjchkq) = idlmgswzts pmyxozyrcw (rvqghmkvwb )
Phase 3
-
aihqrgpusu(fqsahctdag) = Most adverse events were mild/moderate in severity gdfiqjnmbb (rjkvlpfhvk )
Positive
03 May 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free